Summary:
- LifeMD acquires assets from Optimal Human Health MD, boosting its women's health sector.
- Analysts predict an average price target of $12.00, indicating significant upside potential.
- LifeMD rated as "Outperform" with a GF Value estimate suggesting further growth.
LifeMD (LFMD, Financial) is making waves in the healthcare sector with its recent acquisition of key assets from Optimal Human Health MD. This strategic expansion is poised to enhance LifeMD's footprint in the women's health sector, providing a solid clinical foundation for its upcoming virtual health program, which is scheduled to launch this summer on LifeMD's integrated platform.
Wall Street Analysts Forecast
According to projections from nine analysts, LifeMD Inc (LFMD, Financial) boasts an average one-year price target of $12.00. This includes a high estimate of $16.00 and a low of $7.00. The average target represents a potential upside of 97.04% from the current price of $6.09. Investors seeking more detailed estimations can visit the LifeMD Inc (LFMD) Forecast page.
The consensus from nine brokerage firms positions LifeMD Inc's (LFMD, Financial) average brokerage recommendation at 2.0, which aligns with an "Outperform" status. In the rating scale, 1 indicates a Strong Buy, while 5 denotes a Sell, placing LifeMD positively on this spectrum.
Through GuruFocus metrics, the estimated GF Value for LifeMD Inc (LFMD, Financial) in one year is calculated to be $7.03. This suggests a modest upside of 15.44% from the current price of $6.09. The GF Value reflects the fair trading price of the stock, derived from historical trading multiples, past business growth, and future performance estimates. For a more comprehensive view of LifeMD's financials, consider visiting the LifeMD Inc (LFMD) Summary page.
